II. Indications
- Simple Partial Seizures
- Lennox-Gastaut Syndrome
- Complex Partial Seizures
- Generalized Tonic Clonic Seizures
- Bipolar Disorder
III. Mechanism
- Phenyltriazine anticonvulsant
- Enhances Gamma-Aminobutyric Acid (GABA) inhibitory activity
- May also reduce pain transmission, inhibit voltage-gated Sodium channels, suppress Glutamate release, inhibit Serotonin reuptake
IV. Pharmacokinetics
- Oral Bioavailability: 98%
- Elimination Half-Life: 22 to 36 hours
V. Adverse Effects: Common (Dose related)
- Dizziness
- Incoordination
- Tremor
- Ataxia
- Diplopia
- Headache
- Insomnia
- Anxiety
- Agitation (esp. in Autism with Cognitive Impairment)
- Somnolence
- Blurred Vision
- Nausea or Vomiting
VI. Adverse Effects: Serious
- Serious skin rash
- DRESS Syndrome
- Stevens Johnson Syndrome or Toxic Epidermal Necrolysis
- Onset in first 2 to 8 weeks after starting medication
- Incidence 0.3% in adults, 0.8% in children)
- Higher risk when combined with Valproic Acid
- Prolonged QRS Interval
- Increased risk of ventricular Arrhythmia or Cardiac Arrest
- Mechanism
- Higher risk in underlying heart disease
- Coronary Artery Disease (prior Myocardial Infarction)
- Structural heart disease
- Atrioventricular Block
- Heart Failure
- Approach
- Avoid in high risk cardiovascular patients
- Consider baseline EKG in age over 60 years or Cardiovascular Risk Factors
- Avoid combining with other Sodium Channel Blockers
- References
- (2021) Presc Lett 28(6):34
- Aplastic Anemia
- Thrombocytopenia
- Neutropenia
- Pancytopenia
- Aseptic Meningitis
- Serotonin Syndrome
VII. Drug Interactions
- Valproic Acid (requires a decrease in Lamotrigine dose)
- Enzyme-Inducing Anticonvulsants (require an increase in Lamotrigine dose)
-
Oral Contraceptives
- Requires an increase in Lamotrigine dose to as much as double
- Other Interactions
VIII. Precautions
- Slow titration over 6 weeks or more reduces the risk of Stevens-Johnson Syndrome
- Dosing adjustments are needed when used with agents listed under Drug Interactions
- Decrease dose by 25% in moderate to severe hepatic Impairment (50% if Ascites present)
IX. Dosing: Adults (age > 12 years)
- Immediate Release
- Initial: 25 mg orally daily for 2 weeks
- Next: 50 mg orally daily for 2 weeks
- Next: Titrate dose by 50 mg/day divided twice daily every 1 to 2 weeks
- Typical dose: 225 to 375 mg/day divided orally twice daily
- Maximum dose: 400 mg/day divided twice daily
- Extended Release
- Initial: 25 mg orally daily for 2 weeks
- Next: 50 mg orally daily for 2 weeks
- Next: 100 mg orally daily for 1 week
- Next: Titrate dose by 50 mg/day taken daily every 1 week
- Typical dose: 300 to 400 mg/day orally daily
- Dose Adjustment when combined with a non-Valproic Acid, enzyme-inducing anticonvulsant drug or Oral Contraceptives
- Immediate Release Maximum Dose: 300 to 500 mg/day divided twice daily
- Extended Release Maximum Dose: 400 to 600 mg/day
- Dose Adjustment when combined with Valproic Acid
- Immediate Release
- Initial: 25 mg orally every other day for 2 weeks
- Next: 25 mg orally daily for 2 weeks
- Next: Titrate dose by 25 to 50 mg/day daily or divided twice daily every 1 to 2 weeks
- Typical dose: 100 to 200 mg/day daily or divided orally twice daily
- Extended Release
- Initial: 25 mg orally every other day for 2 weeks
- Next: 25 mg orally daily for 2 weeks
- Next: 50 mg orally daily for 1 week
- Next: Titrate dose by 25 to 50 mg/day daily or divided twice daily every 1 to 2 weeks
- Typical dose: 200 to 250 mg orally daily
- Immediate Release
X. Dosing: Children (age 2 to 12 years)
- Immediate Release
- Start: 0.3 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: 0.6 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: Titrate dose by 0.6 mg/kg/day divided twice daily every 1 to 2 weeks
- Typical dose: 4.5 to 7.5 mg/kg/day divided orally twice daily
- Maximum dose: 300 mg/day divided twice daily
- Dose Adjustment when combined with a non-Valproic Acid, enzyme-inducing anticonvulsant drug
- Start: 0.6 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: 1.2 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: Titrate dose by 1.2 mg/kg/day divided twice daily every 1 to 2 weeks
- Typical dose: 5 to 15 mg/kg/day divided orally twice daily
- Maximum dose: 400 mg/day divided twice daily
- Dose Adjustment when combined with Valproic Acid
- Start: 0.15 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: 0.3 mg/kg/day divided orally daily to twice daily for 2 weeks
- Next: Titrate dose by 0.3 mg/kg/day divided twice daily every 1 to 2 weeks
- Typical dose: 1 to 3 mg/kg/day divided orally twice daily
- Maximum dose: 200 mg/day divided twice daily
XI. Monitoring
- Obtain labs monthly for the first 2 months and then every 3 to 12 months
- Complete Blood Count
- Liver Function Test
XII. Approach: Toxicity or Overdose
- Evaluate as Unknown Ingestion
- Obtain other toxicologic screening including Acetaminophen level, Serum Glucose
- Electrocardiogram
- Effects in Overdose
- Ventricular Dysrhythmia
- Lamictal inhibits voltage-gated Sodium channels
- Wide QRS Complex
- Treat with Sodium Bicarbonate ampules until QRS Complex narrows
- Serotonin Syndrome
- Lamictal inhibits Serotonin reuptake
- Neurologic Effects
- Sedation (most common finding in Overdose)
- Seizures
- Paradoxical (as Lamictal is foremost an anticonvulsant)
- Children may experience Seizures at doses >30 mg/kg
- Agitation
- Increased Deep Tendon Reflexes (hyperreflexia)
- Myoclonic Jerks
- Miscellaneous
- Ventricular Dysrhythmia
- Management
- Activated Charcoal
- Consider if <1 hour from time of ingestion, and patient without aspiration risk
- QRS Widening
- See above (regarding bicarbonate)
- Seizures
- See Status Epilepticus
- Benzodiazepines
- Consider Propofol and intubation
- Consider Hemodialysis
- Activated Charcoal
- Disposition
- If asymptomatic at 4-6 hours after ingestion, may discharge home
- References
- Tomaszewski (2020) Crit Dec Emerg Med 34(1): 28
XIII. Safety
XIV. Resources
XV. References
- (2022) Presc Lett, Resource #361206, Antiseizure Medications
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 56-7
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
Images: Related links to external sites (from Bing)
Related Studies
lamotrigine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LAMOTRIGINE 100 MG TABLET | Generic | $0.05 each |
LAMOTRIGINE 150 MG TABLET | Generic | $0.07 each |
LAMOTRIGINE 200 MG TABLET | Generic | $0.08 each |
LAMOTRIGINE 25 MG DISPER TAB | Generic | $0.19 each |
LAMOTRIGINE 25 MG TABLET | Generic | $0.03 each |
LAMOTRIGINE 5 MG DISPER TABLET | Generic | $0.25 each |
LAMOTRIGINE ER 100 MG TABLET | Generic | $1.26 each |
LAMOTRIGINE ER 200 MG TABLET | Generic | $1.08 each |
LAMOTRIGINE ER 25 MG TABLET | Generic | $0.91 each |
LAMOTRIGINE ER 250 MG TABLET | Generic | $3.61 each |
LAMOTRIGINE ER 300 MG TABLET | Generic | $2.99 each |
LAMOTRIGINE ER 50 MG TABLET | Generic | $0.75 each |
LAMOTRIGINE ODT 100 MG TABLET | Generic | $3.05 each |
LAMOTRIGINE ODT 200 MG TABLET | Generic | $4.18 each |
LAMOTRIGINE ODT 25 MG TABLET | Generic | $3.43 each |
LAMOTRIGINE ODT 50 MG TABLET | Generic | $3.57 each |
lamictal (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LAMICTAL 100 MG TABLET | Generic | $0.05 each |
LAMICTAL 150 MG TABLET | Generic | $0.07 each |
LAMICTAL 200 MG TABLET | Generic | $0.08 each |
LAMICTAL 25 MG DISPER TABLET | Generic | $0.19 each |
LAMICTAL 25 MG TABLET | Generic | $0.03 each |
LAMICTAL ODT 100 MG TABLET | Generic | $3.05 each |
LAMICTAL ODT 200 MG TABLET | Generic | $4.18 each |
LAMICTAL ODT 50 MG TABLET | Generic | $3.57 each |
LAMICTAL XR 100 MG TABLET | Generic | $1.26 each |
LAMICTAL XR 200 MG TABLET | Generic | $1.08 each |
LAMICTAL XR 300 MG TABLET | Generic | $2.99 each |
LAMICTAL XR 50 MG TABLET | Generic | $0.75 each |